Revumenib
About
Therapy type: Targeted therapy
Therapy strategy: Menin inhibition
Mappings
NCI Thesaurus: Revumenib (coding:ncit:C165776)
RxNorm: revumenib (coding:rxcui:2698325, coding:omop:1464796)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | t(KMT2A;v) | Acute Lymphoblastic Leukemia | Revumenib | |
| FDA (2) | t(KMT2A;v) | Acute Myeloid Leukemia | Revumenib | |
| FDA (2) | t(KMT2A;v) | Burkitt Lymphoma | Revumenib | |
| FDA (2) | t(KMT2A;v) | Acute Leukemias of Ambiguous Lineage | Revumenib | |
| FDA (2) | NPM1 p.W288Cfs*12 | Acute Myeloid Leukemia | Revumenib |